More information about Brain Lenses at brainlenses.com.
BL supporters receive an additional episode of the show each week. Info about becoming a supporter at the above address, or at Understandary.com.
Read the written version of this episode:
Cravings-Driven Consumption
A diabetes medication called semaglutide has found new and immensely profitable life as an anti-obesity medication (sold as Ozempic, Mounjaro, and others), dramatically improving the financial outlook of several pharmaceutical companies and providing patients suffering the negative health impacts of obesity an effective means of losing a substantial amount of weight, while also reducing other sorts of cravings.
Listen to this episode with a 7-day free trial
Subscribe to Brain Lenses to listen to this post and get 7 days of free access to the full post archives.
